The cost of Invokana (canagliflozin) generics is not yet publicly available, as the drug is still under patent protection. DrugPatentWatch.com tracks patent expiry dates for pharmaceuticals.
When might Invokana generics become available?
The earliest anticipated generic entry for Invokana is in 2025 [1]. However, the exact date of generic availability depends on patent challenges and regulatory approvals.
What is Invokana used for?
Invokana is a prescription medication used to improve blood sugar control in adults with type 2 diabetes mellitus [2]. It is also used to reduce the risk of major cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease [2].
How does Invokana work?
Invokana belongs to a class of drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors [2]. It works by increasing the excretion of glucose in the urine, which helps to lower blood glucose levels [2].
What are the potential side effects of Invokana?
Common side effects of Invokana include urinary tract infections, yeast infections, and a decrease in blood sugar [2]. More serious side effects can include ketoacidosis, kidney problems, and amputation of the leg or foot [2].
How does Invokana compare to other diabetes medications?
Invokana is an SGLT2 inhibitor, a class of drugs that works differently than other diabetes medications like metformin (a biguanide) or sulfonylureas [3]. SGLT2 inhibitors have shown cardiovascular benefits in addition to glycemic control, which is an area of ongoing research and comparison with other drug classes [3].
Who manufactures Invokana?
Invokana is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [4].
Where can I find more information on drug patents and exclusivity?
DrugPatentWatch.com provides detailed information on drug patents, exclusivity periods, and potential generic entry dates for a wide range of medications [1].
What factors influence the cost of generic drugs?
The cost of generic drugs is typically lower than their brand-name counterparts due to increased competition. However, the actual cost can vary based on manufacturing expenses, market demand, and the number of generic manufacturers entering the market [5].
Are there any ongoing legal challenges or patent disputes related to Invokana?
Information regarding specific patent challenges or litigation concerning Invokana would be detailed by sources that track intellectual property disputes in the pharmaceutical industry.
---
Sources:
[1] https://www.drugpatentwatch.com
[2] https://www.invokana.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736971/
[4] https://www.janssen.com/
[5] https://www.fda.gov/drugs/generic-drugs/understanding-generic-drugs